Copland, David A.

Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

Chan, Y. K., Wang, S. K., Chu, C. J., Copland, D. A., Letizia, A. J., Costa Verdera, H., Chiang, J. J., Sethi, M., Wang, M. K., Neidermyer, W. J., et al. (2021) · Science Translational Medicine

Virus-based gene therapy researchRNA Interference and Gene Delivery

Cited by 215

Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations

Kerr, E. C., Raveney, B. J. E., Copland, D. A., Dick, A. D., & Nicholson, L. B. (2008) · Journal of Autoimmunity

Ocular Diseases and Behçet’s SyndromeT-cell and B-cell Immunology

Cited by 162

Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration

Lee, K. S., Lin, S., Copland, D. A., Dick, A. D., & Liu, J. (2021) · Journal of Neuroinflammation

Telomeres, Telomerase, and SenescenceRetinal Diseases and Treatments

Cited by 150

A Perspective of AMD Through the Eyes of Immunology

Copland, D. A., Theodoropoulou, S., Liu, J., & Dick, A. D. (2018) · Investigative Opthalmology & Visual Science

Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome

Cited by 66

Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier

Copland, D. A., Liu, J., Schewitz-Bowers, L. P., Brinkmann, V., Anderson, K., Nicholson, L. B., & Dick, A. D. (2012) · The American Journal of Pathology

Ocular Diseases and Behçet’s SyndromeGlaucoma and retinal disorders

Cited by 50

Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease

Raveney, B. J. E., Copland, D. A., Nicholson, L. B., & Dick, A. D. (2008) · Archives of Ophthalmology

Ocular Diseases and Behçet’s SyndromeGlaucoma and retinal disorders

Cited by 39

Single Eye mRNA-Seq Reveals Normalisation of the Retinal Microglial Transcriptome Following Acute Inflammation

Bell, O. H., Copland, D. A., Ward, A., Nicholson, L. B., Lange, C. A. K., Chu, C. J., & Dick, A. D. (2020) · Frontiers in Immunology

Ocular Diseases and Behçet’s SyndromeNeuroinflammation and Neurodegeneration Mechanisms

Cited by 25

CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions

Abraham, A. R., Maghsoudlou, P., Copland, D. A., Nicholson, L. B., & Dick, A. D. (2023) · Frontiers in Ophthalmology

T-cell and B-cell ImmunologyCAR-T cell therapy research

Cited by 20

Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age

Clare, A. J., Langer, P. M., Ward, A., Chan, Y. K., Dick, A. D., & Copland, D. A. (2025) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 19